Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution
- Conditions
- Dry Eye Syndromes
- Registration Number
- NCT01684852
- Lead Sponsor
- Bitop AG
- Brief Summary
This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
- Male or female person aged 18 years
- Demonstrated mild to moderate keratoconjunctivitis sicca ( "dry eye")
- Acute symptoms of dry eye: DEWS 1-3
- tear break-up time TBUT <10s
- agreement to abide by the routinely provided doctor's appointment for follow-up (reflected in the planned visits of observation plan resist)
- inflammation of the anterior segment or trauma
- Contact lens wearers
- Any disease that can, in the opinion of the treating physician to affect the outcome of the study.
- Patients with known intolerance to one of the substances used
- Surgical procedures to the eyes in the last 6 weeks before inclusion in the trial
- patients with addictive disorders or substance abuse fallow in the past 12 months, as well as persons incapable of giving consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tear Break Up Time V1 and V2
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
Dr. Peter Otto
🇩🇪Bad Liebenwerda, Germany
Augenklinik der LMU Klinikum der Universität Muenchen
🇩🇪Muenchen, Germany
Augenklinik mit Poliklinik
🇩🇪Erlangen, Germany
Dr. Insa Beddermann
🇩🇪Duderstadt, Germany
Augenabteilung am St. Franziskus-Hospital Münster
🇩🇪Muenster, Germany